ENTITY

Scancell Holdings (SCLP LN)

3
Analysis
Health CareUnited Kingdom
Scancell Holdings PLC develops vaccines. The Company uses a human monoclonal antibody to target cells that stimulate immune system response. Scancell's vaccine can be customized against a specific disease.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x